News FDA delays decision on abuse deterrence data on Endo painkil... Data could be used to fend off generic competition.
News Branded pharma condemns UK generic price hiking Newspaper investigation reveals small number of companies hiking the prices of generic drugs.
R&D LSX2026: On a therapeutic vision for ocular disease, with Al... Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
